StockNews.com Begins Coverage on Aspira Women’s Health (NASDAQ:AWH)

Equities research analysts at StockNews.com assumed coverage on shares of Aspira Women’s Health (NASDAQ:AWH) in a report issued on Friday. The firm set a “hold” rating on the stock.

Aspira Women’s Health Price Performance

Shares of NASDAQ:AWH opened at $0.70 on Friday. The stock has a market cap of $11.67 million, a price-to-earnings ratio of -0.58 and a beta of 1.39. Aspira Women’s Health has a 12 month low of $0.67 and a 12 month high of $5.65. The stock’s 50 day moving average price is $0.83 and its 200 day moving average price is $1.14.

Institutional Trading of Aspira Women’s Health

An institutional investor recently bought a new position in Aspira Women’s Health stock. Pine Valley Investments Ltd Liability Co bought a new stake in shares of Aspira Women’s Health Inc. (NASDAQ:AWH) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund bought 31,200 shares of the company’s stock, valued at approximately $25,000. Pine Valley Investments Ltd Liability Co owned 0.19% of Aspira Women’s Health as of its most recent SEC filing. 12.19% of the stock is owned by institutional investors.

About Aspira Women’s Health

Aspira Women's Health Inc, together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States. The company's products include Ova1Plus, a qualitative serum test to assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker test intended to maintain Ova1's high sensitivity; and OvaWatch, a laboratory developed tests to assist in the initial clinical assessment of malignancy risk in all women thought to have an indeterminate or benign adnexal mass.